▶ 調査レポート

世界のCox-2阻害剤市場：市場規模・現状・予測
• 英文タイトル：Global Cox-2 Inhibitors Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のCox-2阻害剤市場：市場規模・現状・予測 / Global Cox-2 Inhibitors Market Size, Status and Forecast 2019-2025 / QYR9N7036資料のイメージです。• レポートコード：QYR9N7036
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、Cox-2阻害剤のグローバル市場について調査・分析したレポートで、種類別（選択的Cox-2阻害剤、非選択的Cox-2阻害剤）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・Cox-2阻害剤の世界市場規模
・主要企業別市場シェア
・Cox-2阻害剤の世界市場規模：種類別（選択的Cox-2阻害剤、非選択的Cox-2阻害剤）
・Cox-2阻害剤の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局）
・Cox-2阻害剤のアメリカ市場規模（種類別、用途別）
・Cox-2阻害剤のヨーロッパ市場規模（種類別、用途別）
・Cox-2阻害剤の中国市場規模（種類別、用途別）
・Cox-2阻害剤の日本市場規模（種類別、用途別）
・Cox-2阻害剤の東南アジア市場規模（種類別、用途別）
・Cox-2阻害剤のインド市場規模（種類別、用途別）
・Cox-2阻害剤の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・Cox-2阻害剤の世界市場予測（2019年-2025年）
・Cox-2阻害剤の地域別市場予測（2019年-2025年）
...

Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.In 2018, the global Cox-2 Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cox-2 Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cox-2 Inhibitors development in United States, Europe and China.

The key players covered in this study
Bayer
Novartis
Pfizer
Merck
Cadila Pharmaceuticals
Sabinsa Corporation
…

Market segment by Type, the product can be split into
Selective Cox-2 Inhibitors
Non Selective Cox-2 Inhibitors

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cox-2 Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the Cox-2 Inhibitors development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cox-2 Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cox-2 Inhibitors Market Size Growth Rate by Type (2014-2025)
1.4.2 Selective Cox-2 Inhibitors
1.4.3 Non Selective Cox-2 Inhibitors
1.5 Market by Application
1.5.1 Global Cox-2 Inhibitors Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cox-2 Inhibitors Market Size
2.2 Cox-2 Inhibitors Growth Trends by Regions
2.2.1 Cox-2 Inhibitors Market Size by Regions (2014-2025)
2.2.2 Cox-2 Inhibitors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cox-2 Inhibitors Market Size by Manufacturers
3.1.1 Global Cox-2 Inhibitors Revenue by Manufacturers (2014-2019)
3.1.2 Global Cox-2 Inhibitors Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cox-2 Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 Cox-2 Inhibitors Key Players Head office and Area Served
3.3 Key Players Cox-2 Inhibitors Product/Solution/Service
3.4 Date of Enter into Cox-2 Inhibitors Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cox-2 Inhibitors Market Size by Type (2014-2019)
4.2 Global Cox-2 Inhibitors Market Size by Application (2014-2019)

5 United States
5.1 United States Cox-2 Inhibitors Market Size (2014-2019)
5.2 Cox-2 Inhibitors Key Players in United States
5.3 United States Cox-2 Inhibitors Market Size by Type
5.4 United States Cox-2 Inhibitors Market Size by Application

6 Europe
6.1 Europe Cox-2 Inhibitors Market Size (2014-2019)
6.2 Cox-2 Inhibitors Key Players in Europe
6.3 Europe Cox-2 Inhibitors Market Size by Type
6.4 Europe Cox-2 Inhibitors Market Size by Application

7 China
7.1 China Cox-2 Inhibitors Market Size (2014-2019)
7.2 Cox-2 Inhibitors Key Players in China
7.3 China Cox-2 Inhibitors Market Size by Type
7.4 China Cox-2 Inhibitors Market Size by Application

8 Japan
8.1 Japan Cox-2 Inhibitors Market Size (2014-2019)
8.2 Cox-2 Inhibitors Key Players in Japan
8.3 Japan Cox-2 Inhibitors Market Size by Type
8.4 Japan Cox-2 Inhibitors Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cox-2 Inhibitors Market Size (2014-2019)
9.2 Cox-2 Inhibitors Key Players in Southeast Asia
9.3 Southeast Asia Cox-2 Inhibitors Market Size by Type
9.4 Southeast Asia Cox-2 Inhibitors Market Size by Application

10 India
10.1 India Cox-2 Inhibitors Market Size (2014-2019)
10.2 Cox-2 Inhibitors Key Players in India
10.3 India Cox-2 Inhibitors Market Size by Type
10.4 India Cox-2 Inhibitors Market Size by Application

11 Central & South America
11.1 Central & South America Cox-2 Inhibitors Market Size (2014-2019)
11.2 Cox-2 Inhibitors Key Players in Central & South America
11.3 Central & South America Cox-2 Inhibitors Market Size by Type
11.4 Central & South America Cox-2 Inhibitors Market Size by Application

12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cox-2 Inhibitors Introduction
12.1.4 Bayer Revenue in Cox-2 Inhibitors Business (2014-2019)
12.1.5 Bayer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cox-2 Inhibitors Introduction
12.2.4 Novartis Revenue in Cox-2 Inhibitors Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cox-2 Inhibitors Introduction
12.3.4 Pfizer Revenue in Cox-2 Inhibitors Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cox-2 Inhibitors Introduction
12.4.4 Merck Revenue in Cox-2 Inhibitors Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Cadila Pharmaceuticals
12.5.1 Cadila Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cox-2 Inhibitors Introduction
12.5.4 Cadila Pharmaceuticals Revenue in Cox-2 Inhibitors Business (2014-2019)
12.5.5 Cadila Pharmaceuticals Recent Development
12.6 Sabinsa Corporation
12.6.1 Sabinsa Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cox-2 Inhibitors Introduction
12.6.4 Sabinsa Corporation Revenue in Cox-2 Inhibitors Business (2014-2019)
12.6.5 Sabinsa Corporation Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Cox-2 Inhibitors Key Market Segments
Table Key Players Cox-2 Inhibitors Covered
Table Global Cox-2 Inhibitors Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cox-2 Inhibitors Market Size Market Share by Type 2014-2025
Figure Selective Cox-2 Inhibitors Figures
Table Key Players of Selective Cox-2 Inhibitors
Figure Non Selective Cox-2 Inhibitors Figures
Table Key Players of Non Selective Cox-2 Inhibitors
Table Global Cox-2 Inhibitors Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Cox-2 Inhibitors Report Years Considered
Table Global Cox-2 Inhibitors Market Size 2014-2025 (Million US$)
Figure Global Cox-2 Inhibitors Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cox-2 Inhibitors Market Size by Regions 2014-2025 (Million US$)
Table Global Cox-2 Inhibitors Market Size by Regions 2014-2019 (Million US$)
Table Global Cox-2 Inhibitors Market Share by Regions 2014-2019
Figure Global Cox-2 Inhibitors Market Share by Regions 2014-2019
Figure Global Cox-2 Inhibitors Market Share by Regions 2019
Table Market Top Trends
Table Global Cox-2 Inhibitors Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cox-2 Inhibitors Market Share by Manufacturers (2014-2019)
Figure Global Cox-2 Inhibitors Market Share by Manufacturers in 2018
Table Global Cox-2 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cox-2 Inhibitors Product/Solution/Service
Table Date of Enter into Cox-2 Inhibitors Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cox-2 Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Global Cox-2 Inhibitors Market Size Share by Type (2014-2019)
Figure Global Cox-2 Inhibitors Market Size Market Share by Type (2014-2019)
Table Global Cox-2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Global Cox-2 Inhibitors Market Size Share by Application (2014-2019)
Figure Global Cox-2 Inhibitors Market Size Market Share by Application (2014-2019)
Figure Global Cox-2 Inhibitors Revenue Market Share by Application in 2018
Figure United States Cox-2 Inhibitors Market Size 2014-2019 (Million US$)
Table United States Key Players Cox-2 Inhibitors Revenue (2018-2019) (Million US$)
Table United States Key Players Cox-2 Inhibitors Market Share (2018-2019)
Table United States Cox-2 Inhibitors Market Size by Type (2014-2019) (Million US$)
Table United States Cox-2 Inhibitors Market Share by Type (2014-2019)
Table United States Cox-2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table United States Cox-2 Inhibitors Market Share by Application (2014-2019)
Figure Europe Cox-2 Inhibitors Market Size 2014-2019 (Million US$)
Table Europe Key Players Cox-2 Inhibitors Revenue (2018-2019) (Million US$)
Table Europe Key Players Cox-2 Inhibitors Market Share (2018-2019)
Table Europe Cox-2 Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Europe Cox-2 Inhibitors Market Share by Type (2014-2019)
Table Europe Cox-2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Europe Cox-2 Inhibitors Market Share by Application (2014-2019)
Figure China Cox-2 Inhibitors Market Size 2014-2019 (Million US$)
Table China Key Players Cox-2 Inhibitors Revenue (2018-2019) (Million US$)
Table China Key Players Cox-2 Inhibitors Market Share (2018-2019)
Table China Cox-2 Inhibitors Market Size by Type (2014-20189) (Million US$)
Table China Cox-2 Inhibitors Market Share by Type (2014-2019)
Table China Cox-2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table China Cox-2 Inhibitors Market Share by Application (2014-2019)
Figure Japan Cox-2 Inhibitors Market Size 2014-2019 (Million US$)
Table Japan Key Players Cox-2 Inhibitors Revenue (2018-2019) (Million US$)
Table Japan Key Players Cox-2 Inhibitors Market Share (2018-2019)
Table Japan Cox-2 Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Japan Cox-2 Inhibitors Market Share by Type (2014-2019)
Table Japan Cox-2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Japan Cox-2 Inhibitors Market Share by Application (2014-2019)
Figure Southeast Asia Cox-2 Inhibitors Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cox-2 Inhibitors Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cox-2 Inhibitors Market Share (2018-2019)
Table Southeast Asia Cox-2 Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cox-2 Inhibitors Market Share by Type (2014-2019)
Table Southeast Asia Cox-2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cox-2 Inhibitors Market Share by Application (2014-2019)
Figure India Cox-2 Inhibitors Market Size 2014-2019 (Million US$)
Table India Key Players Cox-2 Inhibitors Revenue (2018-2019) (Million US$)
Table India Key Players Cox-2 Inhibitors Market Share (2018-2019)
Table India Cox-2 Inhibitors Market Size by Type (2014-2019) (Million US$)
Table India Cox-2 Inhibitors Market Share by Type (2014-2019)
Table India Cox-2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table India Cox-2 Inhibitors Market Share by Application (2014-2019)
Figure Central & South America Cox-2 Inhibitors Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cox-2 Inhibitors Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cox-2 Inhibitors Market Share (2018-2019)
Table Central & South America Cox-2 Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cox-2 Inhibitors Market Share by Type (2014-2019)
Table Central & South America Cox-2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cox-2 Inhibitors Market Share by Application (2014-2019)
Table Bayer Company Details
Table Bayer Revenue in Cox-2 Inhibitors Business (2014-2019) (Million US$)
Figure Bayer Revenue Growth Rate in Cox-2 Inhibitors Business (2014-2019)
Table Bayer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Cox-2 Inhibitors Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Cox-2 Inhibitors Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Cox-2 Inhibitors Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Cox-2 Inhibitors Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Cox-2 Inhibitors Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Cox-2 Inhibitors Business (2014-2019)
Table Merck Recent Development
Table Cadila Pharmaceuticals Company Details
Table Cadila Pharmaceuticals Revenue in Cox-2 Inhibitors Business (2014-2019)(Million US$)
Figure Cadila Pharmaceuticals Revenue Growth Rate in Cox-2 Inhibitors Business (2014-2019)
Table Cadila Pharmaceuticals Recent Development
Table Sabinsa Corporation Company Details
Table Sabinsa Corporation Revenue in Cox-2 Inhibitors Business (2014-2019)(Million US$)
Figure Sabinsa Corporation Revenue Growth Rate in Cox-2 Inhibitors Business (2014-2019)
Table Sabinsa Corporation Recent Development
Table Global Cox-2 Inhibitors Market Size by Regions (Million US$) 2019-2025
Figure Global Cox-2 Inhibitors Market Size Share by Regions (2019-2025)
Figure Global Cox-2 Inhibitors Market Size Share by Regions in 2025
Figure United States Cox-2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cox-2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure China Cox-2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cox-2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cox-2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure India Cox-2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cox-2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Table Global Cox-2 Inhibitors Market Size by Product (2019-2025) (Million US$)
Figure Global Cox-2 Inhibitors Market Size by Product (2019-2025)
Figure Global Cox-2 Inhibitors Market Size by Product in 2025
Table Global Cox-2 Inhibitors Market Size by Application (2019-2025) (Million US$)
Figure Global Cox-2 Inhibitors Market Size by Application (2019-2025)
Figure Global Cox-2 Inhibitors Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界のシグナル伝達阻害剤市場：市場規模・現状・予測
    Global Signal Transduction Inhibitors Market Size, Status and Forecast 2019-2025
    QYR9N8032 2019年6月14日 97Pages
    当資料は、シグナル伝達阻害剤のグローバル市場について調査・分析したレポートで、種類別（ダサチニブ、エルロチニブ、ゲフィチニブ、イマチニブ、ラパチニブ、その他）、用途別（病院薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界のジペプチジルペプチダーゼIV（DPP-IV）阻害剤市場2019
    Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Report 2019
    QYR9N0442 2019年6月10日 105Pages
    本調査レポートでは、ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の世界市場について調査・分析し、ジペプチジルペプチダーゼIV（DPP-IV）阻害剤のメーカー別販売量、市場シェア分析、種類別販売分析（シタグリプチン、ビルダグリプチン、サクサグリプチン、リナグリプチン、その他）、用途別販売分析（病...
  • 世界のPDE阻害剤市場2019
    Global PDE Inhibitors Sales Market Report 2019
    QYR9N3276 2019年6月13日 108Pages
    本調査レポートでは、PDE阻害剤の世界市場について調査・分析し、PDE阻害剤のメーカー別販売量、市場シェア分析、種類別販売分析（PDE5、PDE4、バイアグラ、シアリス、レビトラ、その他）、用途別販売分析（尿生殖器、心血管疾患、神経疾患、皮膚疾患、呼吸器疾患、その他の適応症）、地域別販売分析（米国、...
  • 世界のうつ病性障害市場：市場規模・現状・予測
    Global Depressive Disorder Market Size, Status and Forecast 2019-2025
    QYR9N7087 2019年6月14日 99Pages
    当資料は、うつ病性障害のグローバル市場について調査・分析したレポートで、種類別（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン - ノルエピネフリン再取り込み阻害薬、モノアミンオキシダーゼ阻害剤、セロトニン拮抗薬および再取り込み阻害薬、その他）、用途別（病院、外来手術センター、診断セン...
  • 世界の産後うつ病治療薬市場：市場規模・現状・予測
    Global Postpartum Depression Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7870 2019年6月14日 92Pages
    当資料は、産後うつ病治療薬のグローバル市場について調査・分析したレポートで、種類別（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミンオキシダーゼ阻害剤）、用途別（病院薬局、オンライン薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本...
  • 世界の多発性骨髄腫の治療市場：市場規模・現状・予測
    Global Multiple Myeloma Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7601 2019年6月14日 94Pages
    当資料は、多発性骨髄腫の治療のグローバル市場について調査・分析したレポートで、種類別（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別（病院、診療所、がん治療とリハビリセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本...
  • 世界の多嚢胞性卵巣症候群の治療市場：市場規模・現状・予測
    Global Polycystic Ovarian Syndrome Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7857 2019年6月14日 99Pages
    当資料は、多嚢胞性卵巣症候群の治療のグローバル市場について調査・分析したレポートで、種類別（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、その他）、用途別（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南ア...
  • 世界の皮膚肥満細胞症市場：市場規模・現状・予測
    Global Cutaneous Mastocytosis Market Size, Status and Forecast 2019-2025
    QYR9N7050 2019年6月14日 93Pages
    当資料は、皮膚肥満細胞症のグローバル市場について調査・分析したレポートで、種類別（抗ヒスタミン薬、コルチコステロイド、プロトンポンプ阻害剤、免疫調節剤、肥満細胞安定化剤）、用途別（病院、外来手術センター、その他、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...
  • 世界のクッシング症候群の治療市場：市場規模・現状・予測
    Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7049 2019年6月14日 93Pages
    当資料は、クッシング症候群の治療のグローバル市場について調査・分析したレポートで、種類別（グルココルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...
  • 世界の胃食道逆流症（GERD）治療薬市場：市場規模・現状・予測
    Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7228 2019年6月14日 96Pages
    当資料は、胃食道逆流症（GERD）治療薬のグローバル市場について調査・分析したレポートで、種類別（制酸剤、運動促進剤、H2受容体ブロッカー、プロトンポンプ阻害剤（PPI））、用途別（胸焼け、酸逆流障害）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、...
  • 世界のシグナル伝達阻害剤市場：市場規模・現状・予測世界のシグナル伝達阻害剤市場：市場規模・現状・予測 Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibito…
  • 世界のジペプチジルペプチダーゼIV（DPP-IV）阻害剤市場2019世界のジペプチジルペプチダーゼIV（DPP-IV）阻害剤市場2019 The global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market status and forecast, categorizes the…
  • 世界の産後うつ病治療薬市場：市場規模・現状・予測世界の産後うつ病治療薬市場：市場規模・現状・予測 Postpartum depression is a prevalent disorder affecting many women of reproductive age.Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depres…
  • 世界のPDE阻害剤市場2019世界のPDE阻害剤市場2019 The global PDE Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global PDE Inhibitors market status and forecast, categorizes the global PDE Inhibitors market size (value & volume) by key…
  • 世界のうつ病性障害市場：市場規模・現状・予測世界のうつ病性障害市場：市場規模・現状・予測 Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…